Effects of Alkaline-Reduced Drinking Water on Irritable Bowel Syndrome with Diarrhea: A Randomized Double-Blind, Placebo-Controlled Pilot Study

Effects of Alkaline-Reduced Drinking Water on Irritable Bowel Syndrome with Diarrhea: A Randomized Double-Blind, Placebo-Controlled Pilot Study

Objectives. The purpose of this study was to investigate whether the ingestion of alkaline-reduced water (ARW) is helpful in improving the symptoms of diarrhea-predominant irritable bowel syndrome (IBS). Methods. Twenty-seven patients (male, 25.9%; mean, 41.7 years old) with diarrhea-predominant IBS...

Full description

Bibliographic Details
Main Authors:	Dong Woo Shin, Hyuk Yoon, Hyun Soo Kim, Yoon Jin Choi, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee
Format:	Article
Language:	English
Published:	Hindawi Limited 2018-01-01
Series:	Evidence-Based Complementary and Alternative Medicine
Online Access:	http://dx.doi.org/10.1155/2018/9147914

Similar Items

Inhibitory Effects of β-caryophyllene on Helicobacter pylori Infection: A Randomized Double-blind, Placebo-controlled Study
by: Hyun Ik Shim, et al.
Published: (2019-10-01)

Sex difference in bowel preparation quality and colonoscopy time
by: Young-Jae Hwang, et al.
Published: (2021-03-01)

Doxepin is More Effective than Nortriptyline and Placebo for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Triple-Blind Placebo-Controlled Trial
by: Mohammad Reza Ghadir M.D., et al.
Published: (2011-06-01)

A randomized, double-blind, placebo-controlled study to assess efficacy of mirtazapine for the treatment of diarrhea predominant irritable bowel syndrome
by: Alireza Khalilian, et al.
Published: (2021-02-01)

A randomized, double-blind, placebo-controlled study to assess efficacy of mirtazapine for the treatment of diarrhea predominant irritable bowel syndrome
by: Ahmadimoghaddam, D., et al.
Published: (2021)

Effect of Korean Herbal Medicine Combined with a Probiotic Mixture on Diarrhea-Dominant Irritable Bowel Syndrome: A Double-Blind, Randomized, Placebo-Controlled Trial
by: Seok-Jae Ko, et al.
Published: (2013-01-01)

The Therapeutic Effect of a Multistrain Probiotic on Diarrhea-Predominant Irritable Bowel Syndrome: A Pilot Study
by: Seok-Hoon Lee, et al.
Published: (2018-01-01)

Effect of Colostrum on the Symptoms and Mucosal Permeability in Patients with Irritable Bowel Syndrome: A Randomized Placebo-controlled Study
by: Jin Young Yoon, et al.
Published: (2014-01-01)

Higher levels of disease-related knowledge reduce medical acceleration in patients with inflammatory bowel disease.
by: Jihye Park, et al.
Published: (2020-01-01)

Efficacy of Chinese Herbal Medicine for Diarrhea-Predominant Irritable Bowel Syndrome: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials
by: Jia-Jie Zhu, et al.
Published: (2016-01-01)

The efficacy of Shugan Jianpi Zhixie therapy for diarrhea-predominant irritable bowel syndrome: a meta-analysis of randomized, double-blind, placebo-controlled trials.
by: Ya Xiao, et al.
Published: (2015-01-01)

Effect of Samryungbaekchul-san Combined with Otilonium Bromide on Diarrhea-Predominant Irritable Bowel Syndrome: A Pilot Randomized Controlled Trial
by: Jin-Hyun Lee, et al.
Published: (2019-09-01)

The relationship between drinking alcohol and esophageal, gastric or colorectal cancer: A nationwide population-based cohort study of South Korea.
by: Yoon Jin Choi, et al.
Published: (2017-01-01)

Trends in emergency department visits and hospitalization rates for inflammatory bowel disease in the era of biologics.
by: Gunn Huh, et al.
Published: (2019-01-01)

The place of eluxadoline in the management of irritable bowel syndrome with diarrhea
by: Sherry Levio, et al.
Published: (2017-09-01)

Targeted therapies for diarrhea-predominant irritable bowel syndrome
by: Olden KW
Published: (2012-05-01)

Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome
by: Lacy BE
Published: (2016-02-01)

Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
by: Özdener AE, et al.
Published: (2017-09-01)

The efficacy of Bifidobacterium quadruple viable tablet in the treatment of diarrhea predominant irritable bowel syndrome: protocol for a randomized, double-blind, placebo-controlled, multicenter trial
by: Tao Bai, et al.
Published: (2020-06-01)

Correction: The relationship between drinking alcohol and esophageal, gastric or colorectal cancer: A nationwide population-based cohort study of South Korea.
by: Yoon Jin Choi, et al.
Published: (2018-01-01)

Correction: Trends in emergency department visits and hospitalization rates for inflammatory bowel disease in the era of biologics.
by: Gunn Huh, et al.
Published: (2019-01-01)

Efficacy of probiotics in irritable bowel syndrome: A randomized, double blind placebo-controlled study
by: Md. Zahidur Rahman, et al.
Published: (2016-08-01)

The effect of vitamin D administration on inflammatory markers in patients with inflammatory bowel disease
by: Jae Chang Jun, et al.
Published: (2019-04-01)

Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea
by: Esther Colomier, et al.
Published: (2021-02-01)

Spotlight on eluxadoline for the treatment of patients with irritable bowel syndrome with diarrhea
by: Fragkos KC
Published: (2017-09-01)

Mesalazine Has No Effect on Mucosal Immune Biomarkers in Patients with Diarrhea-Dominant Irritable Bowel Syndrome Referred to Shariati Hospital: A Randomized Double-Blind, Placebo-Controlled Trial
by: Mohammad Reza Ghadir, et al.
Published: (2017-01-01)

Efficacy and safety of drotaverine hydrochloride in irritable bowel syndrome: A randomized double-blind placebo-controlled study
by: Ramesh R Rai, et al.
Published: (2014-01-01)

Gut Microbiota-Bile Acid Crosstalk in Diarrhea-Irritable Bowel Syndrome
by: Kai Zhan, et al.
Published: (2020-01-01)

Characterization of kynurenine pathway in patients with diarrhea-predominant irritable bowel syndrome
by: Pingping Li, et al.
Published: (2020-06-01)

TREATMENT OF DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME WITH MESALAZINE AND/OR SACCHAROMYCES BOULARDII
by: Mauro BAFUTTO, et al.
Published: (2013-12-01)

Fecal Microbiota Alterations Associated With Diarrhea-Predominant Irritable Bowel Syndrome
by: Xiaojun Zhuang, et al.
Published: (2018-07-01)

Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome: The SEPD perspective
by: Isabel Vera, et al.

Clinical potential of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
by: Sobolewska-Włodarczyk A, et al.
Published: (2016-05-01)

The effect of bismuth subcitrate in patients with diarrhea predominant irritable bowel syndrome
by: Kalani M, et al.
Published: (2010-09-01)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
by: Susanta Kumar Padhy, et al.
Published: (2015-10-01)

Symptomatic improvement with gluten restriction in irritable bowel syndrome: a prospective, randomized, double blinded placebo controlled trial
by: Vinay G Zanwar, et al.
Published: (2016-10-01)

Metabolomics analysis of herb-partitioned moxibustion treatment on rats with diarrhea-predominant irritable bowel syndrome
by: Xianwei Lin, et al.
Published: (2019-05-01)

Management of irritable bowel syndrome with diarrhea: a review of nonpharmacological and pharmacological interventions
by: David J. Cangemi, et al.
Published: (2019-10-01)

Brain Functional Interaction of Acupuncture Effects in Diarrhea-Dominant Irritable Bowel Syndrome
by: Kai Ma, et al.
Published: (2020-12-01)

Update on Eluxadoline for the Treatment of Irritable Bowel Syndrome with Diarrhea: Patient Selection and Perspectives
by: Liu R, et al.
Published: (2020-04-01)